356 related articles for article (PubMed ID: 1983390)
21. [Schizophrenic deficit syndrome and neurologic tolerance].
Verdoux H; Bourgeois M
Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
[TBL] [Abstract][Full Text] [Related]
22. The natural history of tardive dyskinesia.
Gardos G; Cole JO; Haskell D; Marby D; Paine SS; Moore P
J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):31S-37S. PubMed ID: 2906068
[TBL] [Abstract][Full Text] [Related]
23. Race and tardive dyskinesia among outpatients at a CMHC.
Glazer WM; Morgenstern H; Doucette J
Hosp Community Psychiatry; 1994 Jan; 45(1):38-42. PubMed ID: 7907310
[TBL] [Abstract][Full Text] [Related]
24. Dyskinesia and neuroleptic exposure in elderly psychiatric inpatients.
Sweet RA; Mulsant BH; Rifai AH; Zubenko GS
J Geriatr Psychiatry Neurol; 1992; 5(3):156-61. PubMed ID: 1353963
[TBL] [Abstract][Full Text] [Related]
25. A comparison of masking effects of haloperidol versus molindone in tardive dyskinesia.
Glazer WM; Hafez H
Schizophr Res; 1990; 3(5-6):315-20. PubMed ID: 1980827
[TBL] [Abstract][Full Text] [Related]
26. Treatment of extrapyramidal side effects with terguride.
Filip V; Marsálek M; Hálková E; Karen P
Psychiatry Res; 1992 Jan; 41(1):9-16. PubMed ID: 1348584
[TBL] [Abstract][Full Text] [Related]
27. Tardive dyskinesia: who is at risk?
van Os J; Fahy T; Jones P; Harvey I; Toone B; Murray R
Acta Psychiatr Scand; 1997 Sep; 96(3):206-16. PubMed ID: 9296552
[TBL] [Abstract][Full Text] [Related]
28. Schizoaffective disorder: a form of schizophrenia or affective disorder?
Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
[TBL] [Abstract][Full Text] [Related]
29. Effects of neuroleptic reduction in schizophrenic outpatients receiving high doses.
Leblanc G; Cormier H; Gagné MA; Vaillancourt S
Can J Psychiatry; 1994 May; 39(4):223-9. PubMed ID: 7913872
[TBL] [Abstract][Full Text] [Related]
30. Tardive dyskinesia presenting as a psychosis.
Asnis GM; Nathan RS; Davies SO; Halbreich U
J Nerv Ment Dis; 1979 Dec; 167(12):762-3. PubMed ID: 41884
[TBL] [Abstract][Full Text] [Related]
31. Tardive dyskinesia: reversible and irreversible.
Casey DE
Psychopharmacology Suppl; 1985; 2():88-97. PubMed ID: 2860664
[TBL] [Abstract][Full Text] [Related]
32. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements.
Brown KW; White T
Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594
[TBL] [Abstract][Full Text] [Related]
33. A placebo-controlled trial of selegiline (L-deprenyl) in the treatment of tardive dyskinesia.
Goff DC; Renshaw PF; Sarid-Segal O; Dreyfuss DA; Amico ET; Ciraulo DA
Biol Psychiatry; 1993 May; 33(10):700-6. PubMed ID: 8102552
[TBL] [Abstract][Full Text] [Related]
34. The effects of clozapine on tardive dyskinesia.
Lieberman JA; Saltz BL; Johns CA; Pollack S; Borenstein M; Kane J
Br J Psychiatry; 1991 Apr; 158():503-10. PubMed ID: 1675900
[TBL] [Abstract][Full Text] [Related]
35. Ten year outcome of tardive dyskinesia during continuous treatment with first generation antipsychotics.
Rittmannsberger H
Psychiatr Danub; 2008 Dec; 20(4):461-5. PubMed ID: 19011586
[TBL] [Abstract][Full Text] [Related]
36. Negative symptoms as a risk factor for tardive dyskinesia in schizophrenia.
Liddle PF; Barnes TR; Speller J; Kibel D
Br J Psychiatry; 1993 Dec; 163():776-80. PubMed ID: 7905774
[TBL] [Abstract][Full Text] [Related]
37. Prospective study of tardive dyskinesia in the elderly: rates and risk factors.
Woerner MG; Alvir JM; Saltz BL; Lieberman JA; Kane JM
Am J Psychiatry; 1998 Nov; 155(11):1521-8. PubMed ID: 9812112
[TBL] [Abstract][Full Text] [Related]
38. Global diagnostic ratings compared to DSM-III-R diagnoses in early dyskinesia.
Gardos G; Cole JO; Samson J; Boling L; Conley C
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):295-310. PubMed ID: 7911586
[TBL] [Abstract][Full Text] [Related]
39. Tardive dyskinesia and positive and negative symptoms of schizophrenia. A study using instrumental measures.
Yuen O; Caligiuri MP; Williams R; Dickson RA
Br J Psychiatry; 1996 Jun; 168(6):702-8. PubMed ID: 8773812
[TBL] [Abstract][Full Text] [Related]
40. Tardive dyskinesia outcomes: clinical and pharmacologic correlates of remission and persistence.
Cavallaro R; Regazzetti MG; Mundo E; Brancato V; Smeraldi E
Neuropsychopharmacology; 1993 May; 8(3):233-9. PubMed ID: 8099483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
